Navigation Links
Genetically corrected blood cells obtained from skin cells from Fanconi anemia patients
Date:6/2/2009

A collaboration research carried out by the teams of Jordi Surralls, Universitat Autnoma de Barcelona (UAB); Juan Carlos Izpisa-Belmonte and ngel Raya, Centre for Regenerative Medicine of Barcelona (CMRB); and Juan Antonio Bueren, Centre for Energetic, Environmental and Technological Research (CIEMAT), has resulted in the generation of blood cells from skin cells of patients with a genetic disease known as Fanconi anemia. The process is based on gene therapy and cell reprogramming techniques in which cells similar to embryonic stem cells known as induced pluripotent stem (iPS) cells can be generated. The research article was published in this week's digital version of Nature.

The research demonstrates that, for the first time, in the case of a genetic disease such as Fanconi anemia it is possible to correct the genetic defect in patient-specific skin cells by converting them into cells similar to embryonic stem cells (iPS cells) which later can be differentiated towards blood cells.

These results are the proof of concept that this new therapeutic strategy has the potential of generating tissues using the very skin of those affected with these genetic diseases. This observation is particularly important in diseases such as Fanconi anemia, where one of the main problems lies in the lack of blood cell in the bone marrow of those affected. However, according to researchers, this new therapeutic strategy can be applied to many other genetic diseases by differentiating iPS cells towards healthy tissues these patients lack.

The generation of blood cells in this research was carried out in vitro, in cell culture plates, which places the research in a preclinical environment. It remains unknown whether they would generate blood cells after being transplanted. Moreover, the transplant of embryonic stem cells in animals has revealed that these cells can cause tumours. Therefore, the possibility of treating Fanconi anemia patients by transplanting iPS cells must wait until the efficacy and safety of these new discoveries are demonstrated in experimental models.

Researchers taking part in the study are confident that in the next few years it will be possible to improve the efficacy and safety of this new scientific discovery, and that some time in the future, clinical professionals will be able to cure patients suffering from genetic diseases such as Fanconi anemia.


'/>"/>

Contact: Maria Jesus Delgado
MariaJesus.Delgado@uab.cat
34-935-814-049
Universitat Autonoma de Barcelona
Source:Eurekalert

Related biology news :

1. Penn Veterinary Medicine report new strategy to create genetically-modified animals
2. Study shows genetically engineered corn could affect aquatic ecosystems
3. Genetically engineered corn may harm stream ecosystems
4. Genetically modified carrots provide more calcium
5. Is political orientation transmitted genetically?
6. Total, genetically-based recall
7. Novel bioreactor enhances interleukin-12 production in genetically modified tobacco plants
8. Researchers genetically link Lou Gehrigs disease in humans to dog disease
9. Scientists unlock possible aging secret in genetically altered fruit fly
10. Cats eye diseases genetically linked to diseases in humans
11. Origins of wolverine in California genetically verified
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2016)... , Jan. 18, 2016  Extenua Inc., ... that simplifies the use and access of ubiquitous ... go-to-market partnership with American Cyber.  ... extensive experience leading transformational C4ISR and Cyber initiatives ... integrating the latest proven technology solutions," said ...
(Date:1/11/2016)... 2016  higi, the leading retail and omni-channel community ... web and mobile, today announced it has closed ... investors. --> --> ... innovate higi,s health platform – its network of ... including expanding services and programs to retail partners ...
(Date:1/7/2016)... , Jan. 7, 2016  A United States District ... first court in the country to interpret a biometric ... to go forward against the photo website Shutterfly brought ... BRIAN NORBERG vs. SHUTTERFLY, INC.; and THISLIFE, ... alleges that Shutterfly violates the Illinois Biometric Privacy Act ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... 2016  Spherix Incorporated (Nasdaq: SPEX ) -- an intellectual ... of intellectual property, today provided an update on the ... District of Texas and announcing ... Inter Partes Re-examination ("IPR") proceedings that VTech and ... was initiated on only certain claims of two of ...
(Date:2/4/2016)... Brooklyn, NY (PRWEB) , ... February 04, 2016 , ... ... cuvettes for over 10 years. What sets them apart from other cuvette ... that is posted on their website. On top of this steady flow of ...
(Date:2/3/2016)... Feb. 3, 2016 Ascendis Pharma A/S (Nasdaq: ... applies its innovative TransCon technology to address significant unmet ... upcoming investor conference.Event:2016 Leerink Partners Global Healthcare Conference Location: ... Wednesday, February 10, 2016 Time:  , 11:55am EST ... --> An audio webcast of this event ...
(Date:2/3/2016)... ... February 03, 2016 , ... ... of potential targets (epitopes) specific to misfolded, propagating strains of Amyloid beta involved ... monoclonal antibody therapeutics for Alzheimer’s. , Following on from the first misfolded Amyloid ...
Breaking Biology Technology: